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Abstract: Beneficial effects of cold atmospheric argon plasma (CAAP) on wound healing and its capacity
for bacterial decontamination has recently been documented. First, in vivo studies in small animals did
not prove any decontamination effect in canine bite wounds. The present study evaluated the overall
decontamination effect of CAAP for different bacteria frequently encountered in canine bite wounds
with respect to growth phase, initial bacteria concentration and treatment duration. Standard strains
of Escherichia (E.) coli, Staphylococcus (S.) pseudintermedius, S. aureus, Streptococcus (S.) canis, Pseu-
domonas (P.) aeruginosa and Pasteurella multocida were investigated. To evaluate the influence of the
bacterial growth phase, each bacterium was incubated for three and eight hours, before CAAP treatment.
Three different bacterial concentrations were created per bacterium and growth phase, and were exposed
to CAAP for 30 s, 1 min and 2 min. CAAP treatment resulted in acceptable decontamination rates (range
98.9-99.9%) in all bacteria species in vitro; however, differences in susceptibility were detected. Decon-
tamination rate was mainly influenced by initial bacterial concentration and treatment time. Growth
phase only influenced decontamination in S. pseudintermedius. Treatment time significantly (P < .05)
correlated with the decontamination rate in E. coli, S. canis and S. aureus, with an exposure time of 2 min
being most effective. Initial bacterial concentration significantly (P < .05) influenced decontamination in
Pasteurella multocida and P. aeruginosa, in which treatment time was not as important. CAAP exerts
effective antibacterial activity against the tested bacteria strains in vitro, with species specific effects of
treatment time, growth phase and concentration.
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Cold atmospheric argon plasma on selected bacteria 
 
Abstract 
Beneficial effects of cold atmospheric argon plasma (CAAP) on wound healing and its 
capacity for bacterial decontamination has recently been documented. First, in vivo studies in 
small animals did not prove any decontamination effect in canine bite wounds. The present 
study evaluated the overall decontamination effect of CAAP for different bacteria frequently 
encountered in canine bite wounds with respect to growth phase, initial bacteria concentration 
and treatment duration. 
Standard strains of Escherichia (E.) coli, Staphylococcus (S.) pseudintermedius, S. aureus, 
Streptococcus (S.) canis, Pseudomonas (P.) aeruginosa and Pasteurella multocida were 
investigated. To evaluate the influence of the bacterial growth phase, each bacterium was 
incubated for three and eight hours, before CAAP treatment. Three different bacterial 
concentrations were created per bacterium and growth phase, and were exposed to CAAP for 
30 seconds, 1 minute and 2 minutes.  
CAAP treatment resulted in acceptable decontamination rates (range 98.9-99.9%) in all 
bacteria species in vitro; however, differences in susceptibility were detected. 
Decontamination rate was mainly influenced by initial bacterial concentration and treatment 
time. Growth phase only influenced decontamination in S. pseudintermedius. Treatment time 
significantly (P<0.05) correlated with the decontamination rate in E. coli, S. canis and S. 
aureus, with an exposure time of 2 minutes being most effective. Initial bacterial 
concentration significantly (P<0.05) influenced decontamination in Pasteurella multocida and 
P. aeruginosa, in which treatment time was not as important. CAAP exerts effective 
antibacterial activity against the tested bacteria strains in vitro, with species specific effects of 
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Introduction 
Microbial multidrug-resistance (MDR) is one of the main issues that must be solved by 
modern medicine (Ogeer-Gyles et al. 2006, Weese 2008). Among surgical patients, surgical 
site infections, and especially open wounds, represent risk groups, and antibiotic treatment 
frequently results in a shift to more resistant bacteria rather than in wound decontamination 
(Harbarth 2007, Weese 2008, Nolff et al. 2016). Recognition f this problem has increased 
research on alternative strategies for wound decontamination, including antiseptic substances 
and physical treatment options in human medicine (Kramer et al. 2004, Assadian 2007). 
However, despite the fact that the same problem exists in small animal surgical patients 
(Weese 2008, Nolff et al. 2016), there is a paucity of studies focusing on antiseptic wound 
treatment in veterinary medicine (Sanchez et al. 1988, Lozier et al. 1992).  
Plasma is a physical state of matter, which is highly energetic. A multimodal effect has been 
postulated, with the microbiocidal effect mainly attributed to reactive oxygen radicals (ROS), 
reactive nitrogen radicals (RNS), energetically enriched ions and charged particles, ultraviolet 
(UV) radiation and a mix f other atoms (Montie et al. 2000, Laroussi 2002, Laroussi and 
Leipold 2004, Matthes et al. 2014, Von Woedtke et al. 2013, Mai-Prochnow et al. 2014).  
Various effects of cold atmospheric plasma on bacteria have been documented. Among these, 
three major impacts lead to cell destruction (Vatansever et al. 2013, Mai-Prochnow et al. 
2014):  
1. Destruction of the bacterial cell membrane  
2. Intracellular protein damage 












Loaded particles, such as ions and electrons, create an electrostatic field that permeates the 
bacterial cell wall (Mendis et al. 2000, Laroussi et al. 2002, Von Woedtke et al. 2013). The 
electrostatic force accumulates on the cell surface until it causes the outward directed cell wall 
force to subside, leading to destruction (Mendis et al. 2000, Laroussi et al. 2002, Mai-
Prochnow et al. 2014). This effect is more profound in Gram-negative bacteria, due to their 
more irregular rough outer membrane. While morphologic cell wall destruction has been 
documented in this Gram-negative bacteria species, no morphological changes occur in 
Gram-positive bacteria (Mendis et al 2000, Laroussi et al. 2002). Thus, less electrostatic force 
is needed to destroy their outer cell wall compared to Gram-p sitive bacteria (Mendis et al. 
2000, Laroussi et al. 2002, Mai-Prochnow et al. 2014).  
In addition, oxidative stress exerts direct effects on proteins and bacterial DNA (Laroussi et 
al. 2009, Von Woedtke et al. 2013). Massive oxidative stress through reactive oxygen radicals 
results in lipid-oxygenation, loss of cellular cytoplasm, proteins and oxidative damage to the 
DNA, leading to cell death once the reparation mechanism is overcome (Gadri et al. 2000, 
Imlay 2003, Joshi et al. 2011, Gaunt et al. 2006, Farr and Kogoma 1991). Prolonged 
exhibition to a plasma effluent results in complete cell fragmentation (Joshi et al. 2011). 
Finally, the cells undergo morphological and chemical changes before inactivation (Joaquin et 
al. 2009, Zhang et al. 2013). The described effects are dose-dependent and individually differ 
between target cells (Daeschlein et al. 2010, Fluhr et al. 2012, Matthes et al. 2013, Flynn et al. 
2015).  
Numerous in vitro and in vivo trials in small mammals and humans have documented an 
effective decontamination effect combined with a wide safety margin regarding a damage of 
eukaryotic cells (Laroussi et al. 2003, Daeschlein et al. 2010, Hammann et al. 2010, 
Ermolaeva et al. 2011, Koban et al. 2011, Fluhr et al. 2012, Lademann et al. 2012, 
Bundscherer et al. 2013, Matthes et al. 2013, Wende et al. 2014, Flynn et al. 2015, Kisch et al. 












Because the effect of plasma is related to numerous factors, a unique ‘dosing’ protocol is not 
available (Laroussi 2009, Von Woedtke et al. 2013). The type of effluent is closely related to 
the carrier gas, the room air and the device used for generation of the plasma state (Laroussi 
2009, Von Woedtke et al., 2013). Furthermore, the distance between the plasma source and 
the wound surface influences the decontamination effect (Taghizadeh et al. 2015). Longer 
treatment times have been observedto result in greater ‘bacterial death’ however, this is 
influenced by bacteria species, growth form (biofilm) and substrate on which the bacteria 
grows (Laroussi et al. 2002, Cooper et al. 2010, Cotter et al. 2011, Brelles-Marino 2012, 
Taghizadeh et al. 2015).  
Other factors, such as growth state (exponential or stationary phase), have been studied before 
by Yu et al. (2006) and initial bacterial concentration was evaluated in context of food 
microbiology. Fernandez et al. (2012) could show, that inactivation of Salmonella 
Typhimurium through CAP treatment is more efficient, the lower the initial bacterial 
concentration is. Despite these well-investigated facts, the first clinical trials evaluating the 
decontaminating effect of CAAP in canine bite wounds were not able to detect any 
decontamination effects in vivo (Winter et al. 2018). Therefore, it was our aim to investigate 
the effect of the used CAAP source in bacteria to be anticipated in canine bite wounds in vitro 
to document the in vitro efficacy and potential influencing factors with respect to bacteria 
species, bacteria growth phase and bacteria concentration. Based on a recent survey on the 
bacterial bio-burden of open treated wounds in small animal patients, the following bacteria 
were chosen for evaluation: Escherichia (E.) coli, Staphylococcus (S.) aureus, Staphylococcus 
(S.) pseudintermedius, Streptococcus (S.) canis, Pasteurella multocida and Pseudomonas (P.) 
aeruginosa (Nolff et al. 2016). 
Our hypothesis was that CAAP would efficiently decontaminate all chosen isolates with an 
exposure time of 2 minutes being most effective. Furthermore, we postulated that this effect 












concentrations would need longer exposure times for decontamination. The aim was to 
investigate the efficiency of CAAP in vitro on selected bacteria before using it in a following 
in vivo study on canine bite wounds.  
 
Materials and methods 
Bacteria selection and culture 
For this investigation, the following bacteria were included for further validation: Escherichia 
coli DSM 1103, Staphylococcus aureus DSM 1104, Staphylococcus pseudintermedius DSM 
21284, Streptococcus canis DSM 20715, Pasteurella multocida DSM 5281 as well as 
Pseudomonas aeruginosa DSM 1117. All strains were obtained from the Leibniz Institute 
DSMZ German Collection of Microorganisms and Cell Cultures. To exclude the potential 
influence of different genetic alterations in wild-type bacteria, standard strains were chosen.  
Bacterial suspensions were prepared using a standard-I-bouillon (No. 1.07882.0500, Merck ) 
at a pH of 7.5 ± 0.2 at 37°C and plated on Mueller-Hinton Agar (No. 1.05435.0500, Merck ). 
Because of growth requirements of the fastidious S. canis and Pasteurella multocida, 
Mueller-Hinton Agar was supplemented with 5% sheep blood. Sheep blood was drawn from 
in-house donors (animal house Schwere Reiter Straße 9, 80797 Munich, sheep blood donor 
registration nr. 55.2-1-54-2532.0-64-2016, government of upper Bavaria). 
 
Determination of the bacterial growth phase 
Bacterial proliferation in an closed system can be divided into four phases: A lag phase with 
no cell division, an exponential growth phase with high metabolic activity and cell division 
followed by a stationary phase, and the death phase. A wound is like an open system where all 
phases of bacterial proliferation can occur. For this study we only used the exponential growth 
and stationary phase for examination. In order to detect differences of the effect of CAAP 












to stationary phase of each bacterium was determined by visual control using the McFarland 
standard. Each enrolled bacterium was incubated in standard I-bouillon at 37°C ± 1°C for 48 
hours with a visual control every 2 hours to document the increase of turbidity until the 
stationary phase was reached (no more detectable increase). McFarland standard was used to 
simplify and keep scope of the trial down. Based on the results of the detected change in 
turbidity, an incubation of 3 hours was representative of exponential growth in all tested 
bacteria, while an incubation of 8 hours was representative of the stationary phase. 
Additionally, CFU´s were counted to confirm the exponential and stationary phase.  
 
Determination of initial bacterial concentration 
For determination of the colony-forming units per square centimetre (CFU/cm2) a log10 serial 
dilution of the inoculum for plating was used. Colony counting was done after 48 hours of 
incubation at 37°C ± 1°C. For treatment with CAAP, three concentrations (10-1, 10-2 and 10-3) 
were plated per strain and per growth phase (6 plates per strain) on Mueller-Hinton Agar. 
After treatment with cold argon plasma, the plates were incubated at 37°C ± 1°C before 
counting colonies in the treated areas. 
   
Cold Argon Plasma Treatment 
The plasma device used in this study (KinPen Vet-NeoPlas) was an atmospheric plasma jet 
with a handheld unit, and consists of a 1 mm pin-tip electrode mounted in the centre of a 
quartz capillary (1.6 mm inner diameter, Figure 1 A). Argon was selected as a working gas at 
a flow of 5 standard litres per minute. The gas is ignited at the tip of the electrode and creates 
a jet-like effluent covering approximately 1 cm². The device consumes 50 W, operated at 230 
V/50-60 Hz. The direct voltage within the plasma is 3 kV and has a dissipated electric 
capacity of 1.5-2 W. At these settings, the effluent has a visible length of 14 mm (Figure 1 B) 












To assure repeatability of treatment, a template was created and placed on the backside of 
each plate for plasma irradiation (Figure 2). Three areas of 1 cm² each were treated with the 
plasma device at an approximate distance of 1 cm above the surface for the duration of 30 
seconds, 1 minute or 2 minutes. The KinPen Vet was therefore moved manually over each 
area in a meandering pattern with parallel lines and with different angles (top-down, from left 
to right, top right at lower left and top left at lower right). This pattern was repeated in 
concern for each given treatment duration. 
After the plasma treatment, plates with isolates of the six bacterial strains were incubated for 
14 to 20 hours at 37°C ± 1°C. S. canis was incubated for 44 to 46 hours due to the small size 
of colonies detected, in order to facilitate easier identification of CFUs. Experiments were 
repeated independently for each bacterial strain with all settings of the experiment. Three 
different log10 dilutions for each bacterial proliferation were plated respectively on agar 
plates. Each agar plate had three areas for CAAP treatment, achieving 18 areas for single 
examination of one bacterial strain. Altogether, 36 areas (n=36) for one and 216 areas (n=216) 
for all six different bacterial strains were examined. This resulted in different concentrations 
between the two tests of the bacterial strains and also for each growth phase. 
 
Calculation of the decontamination effect 
The CFU per plasma treatment zone of 1 cm2 was divided by the CFU per 1 cm2 without 
treatment, calculated from the log10 dilution of the inoculum. The values were given in 
percentage of growth reduction as well as in logarithmic growth reduction. In case CFU could 
not be counted after CAAP treatment, appraisal value was used referring to the untreated area 
of the agar plate. An 8 log reduction has been used for calculation in terms of a 100 % 














Data were computed in Excel (Microsoft Excel 2010) and analysed using SPSS (IBM SPSS 
Statistics 23.0) software. Descriptive statistics were given as mean and standard deviation. 
Effect of treatment with respect to the investigated factors was determined using multivariate 
analysis of variance (ANOVA, SS Type III) and Fisher’s f-test. Treatment time of CAAP, 
bacterial proliferation and initial bacterial concentration were tested regarding their effects on 
the decontamination. Significance was set at P<0.05. 
 
Results 
Decontamination effect with regard to treatment time 
Treatment time represents one of the major aspects of CAAP efficiency. The effect of 
treatment time especially influenced the decontamination of E. coli, S. aureus and S. canis. In 
all three bacterial species, significant effects could be detected (Table 1). However, improved 
bacterial decontamination was observed in all investigated species at both growth phases. The 
most efficient treatment duration was 2 minutes per cm². Minor effects of treatment time were 
observed for E. coli, P. aeruginosa and Pasteurella multocida (Table 1). The influence of 
treatment time in S. aureus was superior to the effect of bacterial concentration. 
In addition to total decontamination, another effect was observed: treatment duration 
correlated with the size of the inhibited area. The zone of inhibition exceeded the border of 
the treated area, despite the fact that all areas were treated based on the template. Extended 
treatment time, especially 2 minutes per cm², increased the zone of inhibition of all tested 
bacteria (Figure 3). 
 
Decontamination effect with regard to bacterial growth phase 
The decontamination rate per growth phase and bacterial strain is shown in Table 2. Higher 
decontamination rates were achieved in growing bacteria of Pasteurella multocida, P. 












this difference was only significant for S. pseudintermedius (P= 0.001). Only S. canis showed 
a slightly higher decontaminating effect in the stationary form. In E. coli, no difference was 
detectable between the two bacterial proliferation phases. 
 
Decontamination effect with regard to initial bacteria concentration 
The decontamination rate per initial concentration and bacteria species is given in Table 3. 
With the exception of E. coli, bacteria concentration significantly influenced decontamination 
in all tested bacteria. This implies that with higher dilution, more effective decontamination is 
achieved through lower bacteria concentration. 
Furthermore the effect of initial concentration (P= 0.000) seems to be higher compared with 
the growth phase (P= 0.001) of S. pseudintermedius. In S. canis, initial concentration (P= 
0.001) has a greater effect compared to treatment time (P= 0.009). 
 
Decontamination effect with regard to bacteria species 
The overall logarithmic growth reduction of bacteria in all treated areas (n=216) ranged 
between log 2.56 and 5.39, in perce tage terms between 71.4 and 99.9%. Treatment of Gram-
negative bacteria (E. coli 99.99% = 5.39 log (n=36), Pasteurella multocida 96.65% = 4.76 log 
(n=36), P. aeruginosa 99.6% = 4.54 log (n=36)) resulted in an improved decontamination 
compared to Gram-positive species (S. canis 93.4% = 3.37 log (n=36), S. aureus 82.1% = 
2.86 log (n=36) and S. pseudintermedius 71.4% = 2.56 log (n=36)).  
 
An overview of initial bacterial concentration of each bouillon, CFUs before and after 
treatment for each serial dilution, treatment time and proliferation phase of respective bacteria 














The aim of this study was to investigate the in vitro efficiency of CAAP on selected bacteria 
frequently encountered in canine bite wounds. Based on the overall effect, CAAP treatment 
seems to represent an interesting alternative to antiseptic wound treatment, especially since no 
known mechanisms for bacterial resistance have been documented in the literature (Heinlin et 
al. 2011, Daeschlein et al. 2012a, Daeschlein et al. 2015). Flynn et al. (2015) even 
documented a high efficiency against so-called ESKAPE bacteria (Enterococcus faecium, 
Staphylocoocus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas 
aeruginosa, Enterobacter spp.), a group of pathogens frequently encountered in hospital-
acquired infections in humans and animals (Weese 2008, Flynn et al. 2015, Nolff et al. 2016). 
However, the first study evaluating its effect in bite wounds in dogs did not find any 
decontaminating effect in vivo at all (Winter et al. 2018). Based on the beneficial results in 
experimental and human applications, this finding seems peculiar. We therefore wanted to 
evaluate the effect of the plasma source used in vivo in dog bite wounds in an in vitro setting 
to evaluate the general efficacy. We were able to prove that several factors impact CAAP 
performance, including initial bacterial contamination, treatment duration, bacterial growth 
phase and bacterial species.  
The bacterial contamination of wounds is something that cannot be influenced through the 
clinician as it occurs before the patient is presented for medical treatment. Nevertheless, this 
study underlines the importance to reduce the contamination rate of wounds as far as possible 
before application of CAAP in order to achieve the maximum effect. In a clinical scenario, 
this can be achieved by debridement and pre lavage, which should always be performed based 
on our in vitro results.  
As previously reported, we could detect a superior decontamination effect on Gram-negative 
bacteria compared with Gram-positive isolates. Laroussi et al. (2003) had previously detected 
superior effects in Gram-negative bacteria. They found that CAP treatment induced cell wall 












negative bacteria compared to untreated controls. In contrast, no differences between treated 
and untreated Gram-positive bacteria were detectable (Laroussi et al. 2003). These findings 
are in concordance with findings documented by Matthes et al. (2013), who reported lower 
decontamination rates for S. epidermidis compared to P. aeruginosa. The accumulation of the 
electrostatic force created by the CAP treatment is more crucial in Gram-negative species. 
This effect has been linked to their irregular rough outer membrane (Mendis et al. 2000, 
Montie et al. 2000, Laroussi et al. 2002). In contrast Lu et al. (2014) described the loss of cell 
integrity and additional DNA damage through time dependent CAP treatment and indicated 
that gram positive bacteria are more sensitive for inactivation induced by CAP than Gram-
negative bacteria. The attending cannot influence the contamination under clinical conditions, 
and frequently there is a mixed flora of Gram-negative and Gram-positive bacteria present 
(Nolff et al. 2016). Despite the influence of bacteria species, the overall effect is still 
profound. Thus, clinical usage without knowledge of the wound status might still be helpful. 
However, if the contamination is known, CAAP is especially useful in treating patients 
affected by Gram-negative bacteria. Gram-positive bacteria should not be disregarded for 
CAAP treatment because of relatively good decontaminating results. 
Yu et al. (2006) investigated the influence of CAP on the mid and late exponential phase as 
well as the stationary phase of treated bacteria. The study showed up, that exponential phases 
of bacteria are generally not more susceptible than their stationary phases, even cells in the 
mid exponential phase showed up a higher resistance than the other ones to plasma treatment. 
Bacteria in the stationary phase are more resistant to inimical processes than bacteria in the 
exponential growth phase (Dodd et al. 1997). It seems logical, that improved metabolism, as 
can be encountered in growing germs, might be linked with increased susceptibility to CAP 
compared to a more resting, stationary phase. We found that this aspect is negligible for most 
Gram-positive and Gram-negative tested bacteria species, with the exception of S. 












interesting, especially as no such difference was detected in S. aureus. However, individual 
differences, even between strains of methicillin-resistant S. aureus (MRSA) have been 
recently described (Matthes et al. 2016).  
We also detected an impact of bacteria concentration on decontamination in all tested bacteria 
despite E. coli, with higher concentrations being less susceptible than lower concentrations. 
This effect was especially profound in S. pseudintermedius and S. canis. Our results agree to 
those of Fernandez et al. (2012), who could equally confirm a higher efficiency of CAP at 
lower bacteria concentration. In contrast to bacteria species and growth phase, bacteria 
concentration can actually be influenced in clinical cases by debridement and intense lavage, 
which should be included to reduce the concentration and treatment time and increase the 
efficiency of CAAP in clinical situations. 
Finally, it was observed that increased treatment time results in increased decontamination, 
with the first decontamination effects visible after 30 seconds and a treatment time of 2 
minutes being most effective. This is in concordance with the results of Matthes et al. (2013), 
who described a time-dependent linear efficiency of decontamination between 30 seconds and 
5 minutes (300 seconds). Dose represents a term that remains under debate for plasma 
applications (Von Woedtke et al. 2013). Several studies have defined treatment time as dose-
dependent; however, the energy level and amount of energy transferred should ideally also be 
included in determining the effective dose (Von Woedtke et al. 2013). Furthermore, other 
adjunctive treatments to CAP can increase the effective dose. It has been proven that 
irradiation of saline solution with CAP induces ionisation in the liquid, lowers the pH and 
alters reactive species within the fluid, making it bactericidal (Von Woedtke et al. 2013). 
Thus, the addition of saline lavage before treatment might exert an even bigger effect than 
pure CAP treatment.  
It is important to consider that CAP dose exerts an impact on bacteria as well as on host cells. 












host (Von Woedtke et al 2013). It has been proven that lower doses of plasma increase 
angiogenesis in host tissue, while higher doses induce cell death (Laroussi 2009, Von 
Woedtke et al. 2013). Fortunately, the lethal dose for bacteria is much smaller than the lethal 
dose for host tissue cells, leaving a wide safety margin for application (Hammann et al 2010, 
Ermolaeva et al. 2011, Koban et al. 2011, Daeschlein et al. 2012b, Lademann et al. 2012, 
Bundscherer et al. 2013, Matthes et al. 2013, Wende et al. 2014, Kisch et al. 2016).   
Based on the significant results achieved in this in vitro trial, we are not able to explain the 
poor performance of CAAP in the clinical situation. We were able to prove, that the used 
device in the used setting is capable of effectively killing the most frequently encountered 
bacteria types. However, the data of the current trial underline the importance of appropriate 
exposure time. The design of the KinPen Vet is adapted to clinical use, facilitating easy 
application and transportability. Unfortunately, the design allows only treatment of a 
relatively small area about 1 cm². The duration of treatment not only influences the rate of 
decontamination but also increases the decontaminated area. This effect has been previously 
described in CAP-treated culture wells and is hypothesized to be a reflection of the plasma jet 
at the surface of the well. Another potential explanation for this inhibitory effect around the 
actual treated area might include the diffusion and activation of oxygen radicals within the 
perimeter of the treated area (Joshi et al. 2010).  
Therefore, a needed dose of 2 minutes per cm² might result in a long treatment time in clinical 
patients, prolonging anaesthesia time and thus increasing the risk for surgical site infections. 
We think that this effect represents the most important clinical limitation. If the results of the 
study by Winter et al. (2018) are interpreted under the light of our current findings, we think 
that the usage of bigger devices, which allow appropriate treatment time under clinical 














CAAP exerts a substantial decontamination effect on bacteria frequently found in animal bite 
injuries in vitro. Even if Gram-negative and positive bacteria are affected differently by CAP 
treatment, there is no formation of complete bacteria resistance (without any effect on 
bacteria), which is why this treatment might present an interesting alternative for local wound 
decontamination in vivo. However, bacteria concentration should initially be reduced as far as 
possible before initiation of CAAP treatment in clinical cases. Furthermore, adequate 
treatment time must be ensured. 
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Figure legends.  
Figure 1. Schematic (A, figure courtesy of INP Greifswald) and life (B) view of the KinPen 
Vet handheld device. 
Figure 2. Template with three areas of 1 cm2 each for CAP treatment for 30 seconds, 1 minute 
or 2 minutes. 
Figure 3. Effect of treatment time (arrowhead, 30 seconds, black arrow, 1 minute, *, 2 
minutes) on different concentrations (left row 10^-1, middle row 10^-2 and right row 10^-3 
bacteria) of Escherichia coli (A), Staphylococcus aureus (B), Staphylococcus 
pseudintermedius (C), Streptococcus canis (D), Pasteurella multocida (E) as well as 
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Table 1. Decontamination rate with respect to treatment time 
 
Bacteria species 





0.5 min 1 min 2 min 0.5 min 1 min 2 min P-value η2 
E. coli 99.98  99.99 100 4.52 5.74* 5.92* 0.001 0.286 
P. multocida 89.97 99.98 99.99 3.97 5.15 5.16 0.096 0.084 
P. aeruginosa 98.71 99.99 100 3.64 4.37 5.59* 0.227 0.045 
S. canis 83.11 97.09 99.96 2.49 3.66 3.95 0.009 0.195 
S. aureus 72.25 79.98 97.90 1.85 2.54 4.18 0.001 0.291 
S. pseudintermedius 67.85 68.19 78.31 2.29 2.40 2.99 0.413 0.021 













Table 2: Decontamination rate with respect to bacterial growth phase 
 
Bacteria species 





exponential stationary exponential stationary P-value η2 
E. coli 99.99  99.99 5.31* 5.48* 0.944 0.000 
P. multocida 97.20 96.10 4.68 4.84 0.879 0.001 
P. aeruginosa 99.98 99.14 4.53* 4.54* 0.718 0.004 
S. canis 92.49 94.28 3.09 3.64 0.373 0.025 
S. aureus 87.66 79.09 3.18 2.54 0.428 0.020 
S. pseudintermedius 84.15 58.75 3.31 1.81 0.001 0.295 













Table 3: Decontamination rate with respect to bacterial concentration 
 
Bacteria species 


















E. coli 99.99 99.99 99.99 6.75* 4.88 4.55 0.127 0.071 
P. multocida 89.98 99.98 99.98 4.43 5.09 4.51 0.004 0.234 
P. aeruginosa 98.74 99.98 99.97 5.15* 4.40 4.06 0.004 0.228 
S. canis 80.80 99.55 99.81 2.27 4.08 3.74 0.001 0.282 
S. aureus 72.08 78.30 99.76 1.53 2.57 4.47 0.021 0.157 
S. pseudintermedius 30.98 84.56 98.81 0.92 3.13 3.63 0.000 0.352 













Table 4. Overview of countable CFU’s before and after cold argon plasma treatment with 
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Countable CFU’s in area after treatment 
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